Enanta Pharmaceuticals, Inc.

United States of America


 
Total IP 429
Total IP Rank # 2,982
IP Activity Score 3.2/5.0    241
IP Activity Rank # 2,909
Stock Symbol
ISIN US29251M1062
Market Cap. 169M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

204 4
27 2
189 3
0
 
Last Patent 2025 - Pharmaceutical compounds and com...
First Patent 2000 - 14-membered macrolides derived f...
Last Trademark 2022 - ENANTA PHARMACEUTICALS
First Trademark 2002 - ENANTA PHARMACEUTICALS

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Pharmaceutical compounds and compositions as c-kit kinase inhibitors. The invention provides com...
Invention Processes for the preparation of oxadiazolylamino benzodiazepine derivatives. The present invent...
Invention Processes for the preparation of oxadiazolylamino benzodiazepine derivatives. The present inventi...
Invention Pharmaceutical compounds and compositions as c-kit kinase inhibitors. The invention provides comp...
Invention Compounds and compositions as c-kit kinase inhibitors. The invention provides compounds of formu...
Invention Compounds and compositions as c-kit kinase inhibitors. The invention provides compounds of formul...
Invention Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof. The present inventio...
Invention Hepatitis b antiviral agents. The present invention discloses compounds of Formula (I), or pharm...
Invention Antiviral heterocyclic compounds. The present invention discloses compounds of Formula (I), or p...
Invention Antiviral heterocyclic compounds. The present invention discloses compounds of Formula (I), or ph...
Invention Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof. The present invention pro...
Invention Fused heterotetracyclic antiviral agents. The present invention discloses compounds of Formula (...
Invention Fused heterotetracyclic antiviral agents. The present invention discloses compounds of Formula (I...
Invention Benzodiazepine derivatives as rsv inhibitors. The present invention discloses compounds of Formu...
Invention Fused heterobicyclic antiviral agents. The present invention discloses compounds of Formula (I),...
2023 Invention Covalent inhibitors as antiviral agents. The present invention discloses compounds of Formula (I...
Invention Novel covalent inhibitors as antiviral agents. The present invention discloses compounds of Formu...
Invention Functionalized heterocycles as antiviral agents. The present invention discloses compounds of Fo...
Invention Macrocyclic chalcone-amide derived antiviral agents. The present invention discloses compounds o...
Invention Novel macrocyclic chalcone-amide derived antiviral agents. The present invention discloses compou...
Invention Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof. ...
Invention Crystal forms of an anti-sars cov-2 agent. The present invention features crystalline forms of C...
Invention Crystal forms of an anti-sars cov-2 agent. The present invention features crystalline forms of Co...
Invention Fused heterobicyclic antiviral agents. The present invention discloses compounds of Formula (I), ...
Invention Pyrimidinone-containing 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors. The present inv...
Invention Antiviral compounds. The present invention discloses compounds of Formula (I), or pharmaceuticall...
Invention Pyrimidinone-containing 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors
Invention Pyrimidinone-containing 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors. The present inve...
Invention Antiviral heterocyclic compounds. The present invention discloses compounds of Formula (I), and ...
Invention Antiviral heterocyclic compounds
Invention Antiviral heterocyclic compounds. The present invention discloses compounds of Formula (I), and p...
Invention Spiropyrrolidine derived antiviral agents. The present invention discloses compounds of Formula (...
Invention Novel spiropyrrolidine derived antiviral agents. The present invention discloses compounds of For...
Invention Processes for the preparation of substituted spirooxindole derivatives
Invention Processes for the preparation of substituted spirooxindole derivatives. The present invention rel...
Invention Processes for the preparation of substituted spirooxindole derivatives. The present invention re...
Invention Hepatitis b antiviral agents. which inhibit the protein(s) encoded by hepatitis B virus (HBV) or...
Invention Processes for the preparation of 4,6,7-trifluoro-1h-indole-2-carboxylic acid. The present inventi...
2022 Invention Heterocyclic antiviral agents. The present invention discloses compounds of Formula (I), and phar...
Invention Saturated spirocyclics as antiviral agents. The present invention discloses compounds of Formula ...
G/S Pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical a...
G/S Pharmaceutical preparations for the treatment of viral infections and hepatic diseases and disor...
G/S Pharmaceutical preparations for the treatment of viral infections and hepatic diseases and disord...
G/S Pharmaceutical preparations for the treatment of viral infections and hepatic diseases and disorders
2002 G/S research and development services in the field of identification of compounds as potential therap...